C ase History: A 62-year-old male with a history of hypertension and coronary artery disease with prior stenting to the left circumflex artery presented with chest pain. Echocardiography on admission demonstrated a globally reduced ejection fraction of 10% to 15% with regional wall-motion abnormality consistent with prior anterior and inferolateral infarction. End-diastolic volume of the left ventricle (LV) was 210 mL. Coronary angiography showed evidence of multivessel disease, with 100% occlusion of the left anterior descending coronary artery, 70% in-stent restenosis of the left circumflex artery, and 90% stenosis of the posterior descending artery. To evaluate for the presence of ischemia, the patient underwent a rest-stress myocardial perfusion imaging study, which showed a large area of moderate ischemia throughout the mid left anterior descending coronary artery territory. In addition, there was a small area of scar in the proximal left circumflex artery territory (Figure 1) . Clinical discussion ensued as to whether this patient would benefit from bypass surgery or percutaneous revascularization.
Introduction
Prospective identification of patients with ischemic heart failure who may benefit from high-risk revascularization remains a clinical challenge. The prediction of functional, symptomatic, and survival benefit depends on multiple factors, including the quality of the target vessels for revascularization, the magnitude of myocardial ischemia and viability, the degree of LV remodeling after myocardial infarction (MI), and other clinical factors. 1, 2 This Clinician Update reviews the optimal patient selection for referral for viability assessment, the rationale for noninvasive assessment of myocardial ischemia and viability, the strengths and weaknesses of the available imaging modalities, the impact of LV remodeling on recovery of LV function and survival, and the optimal time frame from presentation to noninvasive assessment and revascularization.
When Is Assessment of Myocardial Ischemia and Viability Clinically Important?
LV function is a well-established and powerful predictor of prognosis after MI. The occurrence of severe LV systolic dysfunction after MI, especially if associated with heart failure, is associated with very poor survival. Differentiation between LV dysfunction caused by infarction, necrosis, and scar tissue formation versus LV dysfunction due to ischemic but viable myocardium has important implications. Identification of the latter group of patients with these potentially reversible causes of heart failure may be associated with substantial survival benefit, symptomatic improvement, and improved LV function with revascularization. 3, 4 Determination of the risk-versusbenefit ratio from high-risk revascularization in patients with ischemic LV dysfunction is not always clear-cut. Multiple factors are known to influence clinical outcomes. The clinical decision to revascularize is generally straightforward in patients with severe LV dysfunction, severe anginal symptoms, mild LV remodeling, adequate target vessels for revascularization, and minimal comorbidities. 3 In this patient group, clinical improvement has not always been associated with an improvement in LV function. 5 Survival benefit in these patients likely results from revascularization of myocardial territories in jeopardy, thereby preventing cell death and ultimately adverse clinical events. Consequently, evaluation of stress-induced ischemia is essential to define the magnitude of potentially salvageable, viable but ischemic myocardium.
Decisions regarding referral for high-risk revascularization are more difficult in the elderly with several comorbidities (predominantly heart failure symptoms) and prior revascularization, combined with low ejection fraction and advanced LV remodeling. In this frail patient group, the absence of anginal symptoms has often been associated with the absence of myocardial ischemia or viability and a lower likelihood of clinical benefit from revascularization. However, dyspnea may be an anginal equivalent in many of these patients, and may reflect the presence of large areas of ischemia, hibernation, or stunning rather than scar. Indeed, clinically significant residual viability may be found in a significant number of patients with predominantly heart failure symptoms. 6 Despite the higher clinical risk, the presence of ischemia or viability in these patients has been associated with improved outcomes after revascularization. 7 Thus, noninvasive assessment of myocardial ischemia and viability may provide crucial information for the identification of patients who will benefit from high-risk revascularization.
Noninvasive Imaging Approaches to Assess Myocardial Ischemia and Viability
Nuclear medicine techniques such as thallium 201 ( 201 Tl) or technetium Tc 99m ( 99m Tc) single photon emission computed tomography (SPECT) and The LV is severely dilated (end-diastolic volume of 335 mL), and LV ejection fraction is reduced at 18%. There is a large and severe perfusion defect throughout the anterior and anteroseptal walls and the LV apex, consistent with extensive stress-induced ischemia throughout the left anterior descending coronary artery territory. In addition, there is an associated small area of fixed perfusion deficit that involves the basal inferior and inferolateral walls, consistent with scar in the left circumflex artery territory indicated. B, Three-dimensionally rendered reconstructions of the LV demonstrating the quantitative extent and severity of perfusion deficit (blackout region) and the magnitude of stress-induced ischemia or defect reversibility (pink).
fluorodeoxyglucose F 18 ( 18 F-FDG)positron emission tomography (PET)/ computed tomography evaluate cell membrane integrity and myocyte metabolism and thus cell viability. After injection, the initial myocardial uptake of 201 Tl is dependent on myocardial blood flow; however, the subsequent retention of 201 Tl 3 to 4 hours after injection is an active, energy-requiring process that is a function of cell membrane integrity and tissue viability. 8 Like 201 Tl, the uptake and retention of 99m Tc-labeled agents require an intact cell membrane. The latter approach is comparable to 201 Tl except in areas of severe perfusion deficit, where it tends to underestimate the degree of viability. 9 The dependence of glucose for energy metabolism by ischemic myocardium is the rationale for the use of [ 18 F]-FDG PET/computed tomography for viability assessment. Dysfunctional myocardium with preserved glucose uptake denotes the presence of viability and the potential for recovery after revascularization. The augmentation of contractility (so-called contractile reserve) in response to dobutamine stress is the basis for the use of stress echocardiography. Dysfunctional myocardium that is able to show a transient improvement in systolic function in response to dobutamine (contractile reserve) is considered viable; conversely, a lack of improvement in regional systolic function with dobutamine is considered to reflect the absence of potentially reversible dysfunctional myocardium. 10 The contractile reserve in response to dobutamine can also be investigated with cardiac magnetic resonance (CMR; Figure 2 ).
Direct imaging of myocardial scar forms the basis of gadoliniumenhanced CMR. Gadolinium is an extracellular contrast agent that accumulates in areas of myocardial scar due to the greatly expanded extracellular space. With this approach, myocardial scar shows as bright areas (white) on CMR (so-called late gadolinium enhancement; Figure 3 ). Unlike nuclear medicine techniques, the increased spatial resolution of CMR allows delineation of the transmural extent of scar tissue. The addition of dobutamine stress imaging to CMR may help differentiate ischemic from nonischemic cardiomyopathy and may refine predictions of functional recovery after revascularization, especially in areas with nontransmural scar. 11 Similar to late gadolinium enhancement with CMR, cardiac computed tomography can also be used for direct imaging of myocardial scar. 12, 13 Cardiac computed tomography has submillimeter spatial resolution, but with these thin slices, contrast resolution is limited by low signal-to-noise ratio.
Relative Accuracy of Methods for Viability Assessment
Uncertainty persists concerning the relative accuracies of methods for predicting recovery of LV function and outcomes after revascularization. Available data suggest that both SPECT and especially PET are highly sensitive (85% to 90% [sensitivity of PET] versus 70% to 75% [sensitivity of SPECT]), with a higher negative predictive value than with dobutamine echocardiography. Dobutamine echocardiography has the advantage of a higher specificity and a higher positive predictive accuracy than the scintigraphic methods (Figure 4 ). 14, 15 Although the experience with contrastenhanced magnetic resonance imaging is more limited, recent results suggest that it offers similar predictive accura- cies as those seen with dobutamine echocardiography. 16
Selecting the Approach for Assessment of Myocardial Viability
Predictive accuracies (Figure 4 ; Table) are influenced by the level of local expertise. 14, 15 It remains unclear whether some patient subsets are better evaluated by a particular test or perhaps a combination of tests ( Table) . 11, 14, 17, 18 The reported diagnostic accuracies of each of these imaging approaches to predict recovery of LV function have been highly variable. The reasons for these highly variable results are not well understood. However, because the probability of improvement in LV function after revascularization is multifactorial, it is likely that relying on any 1 of these indices of tissue viability or its absence in isolation will lead to suboptimal clinical results. 2 Indeed, it is now evident that other factors, including the presence and magnitude of stressinduced ischemia, the stage of cellular degeneration within viable myocytes, the degree of LV remodeling, the timing and success of revascularization procedures, and the adequacy of the target coronary vessels, can affect the functional outcome after revascularization. Thus, a combination of tests that provide complementary insights regarding cellular viability may be beneficial for more accurate predictions of functional recovery in highrisk patients. Evaluation of the probability of functional recovery after revascularization can be significantly enhanced by the use of predictive models that incorporate clinical and imaging data. 1
Applying Myocardial Viability Information to Management Decisions
The demonstration of viable myocardium in patients with coronary artery disease and LV dysfunction consistently identifies patients with particularly poor prognosis when treated with medical therapy alone. These patients have improved survival and fewer symptoms with prompt revascularization. 19 These findings have been confirmed with nuclear testing or echocardiography. 7 Indeed, a recent meta-analysis by Allman et al 7 reported on the pooled results of 24 studies that documented long-term patient outcomes after viability imaging by SPECT, PET, or dobutamine echocardiography in 3088 patients (2228 men, 860 women) with a mean ejection fraction of 32Ϯ8% and follow-up for 25Ϯ10 months. In patients with evidence of viable myocardium, a strong association was present between revascularization and improved outcomes, particularly in patients with severe LV dysfunction. There was no apparent benefit for revascularization over medical therapy in the absence of viability. There was also a trend toward higher death and nonfatal event rates with revascularization, which could reflect the higher procedural risk for patients with severe LV dysfunction associated with the revascularization itself in the absence of a balancing clinical benefit. Multivariate modeling (meta-regression) of pooled data in patients with viable myocardium demonstrated that as the severity of LV dysfunction increases and the LV ejection fraction decreases, the potential benefit (reduction in risk of death and nonfatal events) associated with revascularization increases. Thus, despite the increased risk of revascularization with worsening LV dysfunction, noninvasive imaging evidence of preserved viability may suggest a net clinical benefit. Figure 2 . Cine mid short-axis magnetic resonance imaging images at baseline and in response to increasing doses of dobutamine. The baseline images demonstrate mild LV dilatation with moderate inferior and inferolateral wall hypokinesis, which improves at 20 g ⅐ kg Ϫ1 ⅐ min Ϫ1 (low dose) of dobutamine and then worsens at 40 g ⅐ kg Ϫ1 ⅐ min Ϫ1 (high dose), illustrating the so-called biphasic response that reflects viable but ischemic myocardium in the posterior descending territory. Full-motion cines can be viewed in the online-only Data Supplement.
Additional Factors That Affect Clinical Outcomes After Revascularization

Degree of LV Remodeling
MI, especially an MI that is large and transmural, can produce alterations in both the infarcted and noninfarcted regions that result in changes in LV architecture known as LV remodeling. In addition to the early thinning and elongation that occur in the infarcted myocardium (infarct expansion), there are secondary changes in the nonin-farcted zone. These include a timedependent increase in the end-diastolic length of viable myocytes that contributes to the overall process of LV enlargement. Although this acute increase in cavity size tends to maintain pump function, this process usually leads to progressive ventricular dilation, heart failure, and decreased survival.
Increased LV volumes and cavity size predict poor outcome in patients with ischemic cardiomyopathy undergoing revascularization. Echocardiography (2-and 3-dimensional) and CMR imaging can accurately determine LV volumes. LV end-diastolic dimension greater than or equal to twice normal (Ն70 mm) predicts poor prognosis after revascularization because it indicates the presence of multiple segments of scarred and nonviable myocardium 20, 21 ; once this degree of LV remodeling and these ventricular dimensions have been reached, even if viability is documented, revascularization has not been shown to be associated with clinical benefit. 22, 23 More recent data from the STICH trial (Surgical Treatment for Ischemic Heart Failure) 24 demonstrated that surgical revascularization reduced LV end-systolic volume by only 6% from baseline, which suggests a modest reverse-remodeling effect.
Timeliness of Revascularization
There is mounting evidence that myocardial hibernation represents an incomplete adaptation to ischemia. The precarious balance between impaired perfusion and viability cannot be maintained indefinitely. Cellular degeneration and eventually myocardial necrosis will occur if blood flow is not increased in a timely manner. The severity of morphological degeneration appears to correlate with the timing and degree of functional recovery after revascularization. 25, 26 Thus, the early hazard associated with the presence of ischemic but viable tissue suggests that prompt revascularization may provide the greatest survival benefit. Figure 3 . Example of stress, rest, and delayed CMR images in a man with known coronary artery disease, prior MI, and stenting of the left anterior descending coronary artery. Images represent mid short-axis views of the LV. The stress images demonstrate extensive anterior, anterolateral, and septal subendocardial hypoperfusion (arrows). The rest images demonstrate residual areas of subendocardial perfusion deficit in the anterolateral and septal walls, which match the area of gadolinium enhancement on the delayed images. This study is consistent with a large area of prior MI throughout the left anterior descending coronary artery territory with evidence of some residual stress-induced peri-infarct ischemia. 
Conclusions
Decisions about revascularization in patients with heart failure symptoms and LV dysfunction are influenced by factors that do not always correlate with documented LV functional improvement. Choice of imaging modality depends on local expertise and patientspecific factors. A combination of modalities may be required. The incorporation of an assessment of ischemia with viability assessment can provide valuable additional information for patient selection for revascularization.
Follow-Up of Case
In light of the dilated LV, severe LV dysfunction, and potential surgical morbidity and mortality, our patient received percutaneous therapy, with successful stenting of the left anterior descending and right coronary arteries. Three months after percutaneous intervention, the patient has no anginal symptoms and has New York Heart Associa-tion class 1 heart failure despite an ejection fraction of 15% to 20%. 
